RESEARCH TRIANGLE PARK – In a huge survey, IBM finds that more shoppers are making buying decisions based on values and trust. Meanwhile, LabCorp is expanding gene editing commitments. Plus life science news from WakeMed, BDSI, Dova and Precision Biosciences. Plus, there’s a new exect at CloudJumper.
Check out these links:
- IBM says purpose-driven shoppers are changing retail
- LabCorp, Convance expand gene therapy development efforts
- WakeMed picks Utah firm to provide data, analytics platform
- BDSI expects to hit ‘high end’ of revenue forecast
- Dova Pharma receives orphan drug status for treatment of chemotherapy side effects
- Gene editing firm Precision Biosciences receives new drug application OK from FDA
- Garner-basefd CloudJumper names enterprise sales manager
